{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:18:26Z","timestamp":1773296306576,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.vaccine.2007.08.022","type":"journal-article","created":{"date-parts":[[2007,9,4]],"date-time":"2007-09-04T12:42:51Z","timestamp":1188909771000},"page":"7858-7865","source":"Crossref","is-referenced-by-count":17,"title":["Immunogenicity and safety of pneumococcal 7-valent conjugate vaccine (diphtheria CRM197 protein conjugate; Prevenar\u2122) in Korean infants: Differences that are found in Asian children"],"prefix":"10.1016","volume":"25","author":[{"given":"Nam-Hee","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jina","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Hyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoan-Jong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.08.022_bib1","series-title":"Counting processes and survival analysis","author":"Fleming","year":"1991"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.022_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0163-4453(96)92681-X","article-title":"Antibiotic resistance and serotypes of Streptococcus pneumoniae at Birmingham Public Helath Laboratory, 1989\u201394","volume":"33","author":"Boswell","year":"1996","journal-title":"J Infect"},{"issue":"18","key":"10.1016\/j.vaccine.2007.08.022_bib3","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0264-410X(98)00132-7","article-title":"Epidemiology of emerging pneumococcal drug resistance: implications for treatment and prevention","volume":"16","author":"Butler","year":"1998","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2007.08.022_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199508243330803","article-title":"The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta","volume":"333","author":"Hofmann","year":"1995","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.022_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2007.08.022_bib6","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/00365540310013315","article-title":"Capsular types and antibiotic susceptibility of invasive Streptococcus pneumoniae among children in Sweden","volume":"35","author":"Hedlund","year":"2003","journal-title":"Scand J Infect Dis"},{"issue":"23","key":"10.1016\/j.vaccine.2007.08.022_bib7","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1001\/jama.268.23.3323","article-title":"Epidemiology of invasive pneumococcal infections in children in Finland","volume":"268","author":"Eskola","year":"1992","journal-title":"JAMA"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2007.08.022_bib8","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1016\/S0264-410X(01)00055-X","article-title":"Pneumococcal conjugate vaccines in Europe, Berlin, Germany, 23\u201325 August 2000. Report of a European advisory board meeting","volume":"19","author":"Schmitt","year":"2001","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2007.08.022_bib9","first-page":"846","article-title":"Serotypes and penicillin susceptibility of Streptococcus pneumoniae isolated from clinical specimens and healthy carriers of Korean children","volume":"46","author":"Lee","year":"2003","journal-title":"J Korean Pediatr Soc"},{"issue":"2","key":"10.1016\/j.vaccine.2007.08.022_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.14776\/kjpid.2006.13.2.89","article-title":"Changes of serotype distribution of Streptococcus pneumoniae isolated from children in Korea over a 15 year-period (1991\u20132005)","volume":"13","author":"Kim","year":"2006","journal-title":"Korean J Pediatr Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.022_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2007.08.022_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.inf.0000151022.92222.be","article-title":"Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age","volume":"24","author":"Kayhty","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.022_bib13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.inf.0000207483.60267.e7","article-title":"Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers","volume":"25","author":"Goldblatt","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2007.08.022_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"issue":"4 Pt 1","key":"10.1016\/j.vaccine.2007.08.022_bib15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1542\/peds.101.4.604","article-title":"Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants","volume":"101","author":"Rennels","year":"1998","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.vaccine.2007.08.022_bib16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00006454-199909000-00004","article-title":"Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers","volume":"18","author":"Shinefield","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"20","key":"10.1016\/j.vaccine.2007.08.022_bib17","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJM199011153232005","article-title":"Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentration in Apache children","volume":"323","author":"Siber","year":"1990","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2007.08.022_bib18","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1093\/infdis\/165-Supplement_1-S144","article-title":"Prevention of Haemophilus influenzae type b infections in Apache and Navajo children","volume":"165","author":"Santosham","year":"1992","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.022_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.14776\/kjpid.2001.8.1.53","article-title":"Epidemiology of invasive Haemophilus influenzae infections and vaccine policy in Korea","volume":"6","author":"Lee","year":"1999","journal-title":"Korean J Pediatr Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.022_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1086\/313907","article-title":"Immunogenicity of a heptavalent pneumococcal conjugate vaccine in Apache and Navajo Indian, Alaska native, and non-native American children aged <2 years","volume":"31","author":"Miernyk","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.022_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/IAI.73.1.369-377.2005","article-title":"Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial","volume":"73","author":"Ekstrom","year":"2005","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.022_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00006454-199803000-00008","article-title":"Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory","volume":"17","author":"Ahman","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2007.08.022_bib23","unstructured":"World Health Organization. Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Technical Report Series, No. 927; 2005."},{"issue":"9381","key":"10.1016\/j.vaccine.2007.08.022_bib24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(03)14022-6","article-title":"Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial","volume":"362","author":"O\u2019Brien","year":"2003","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.vaccine.2007.08.022_bib25","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.vaccine.2007.08.022_bib26","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants","volume":"21","author":"Jodar","year":"2003","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2007.08.022_bib27","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0929-6646(09)60148-0","article-title":"Safety and immunogenicity of heptavalent pneumococcal conjugate vaccine booster in Taiwanese toddlers","volume":"105","author":"Shao","year":"2006","journal-title":"J Formos Med Assoc"},{"issue":"14","key":"10.1016\/j.vaccine.2007.08.022_bib28","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Active Bacterial Core Surveillance of the Emerging Infections Program Network. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae","volume":"354","author":"Kyaw","year":"2006","journal-title":"N Engl J Med"},{"issue":"9546","key":"10.1016\/j.vaccine.2007.08.022_bib29","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.vaccine.2007.08.022_bib30","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.vaccine.2007.08.022_bib31","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/00006454-200112000-00002","article-title":"Postlicensure evaluation of the effectiveness of seven-valent pneumococcal conjugate vaccine","volume":"20","author":"Black","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2007.08.022_bib32","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/infdis\/174.6.1352","article-title":"Nasopharyngeal colonization in southern Israel with antibiotic-resistant pneumococci during the first 2 years of life: relation to serotypes likely to be included in pneumococcal conjugate vaccines","volume":"174","author":"Dagan","year":"1996","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T20:14:24Z","timestamp":1556828064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07009231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":32,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0264410X07009231"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.08.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}